Search results
Results from the WOW.Com Content Network
Anti-asthmatic agents, also known as anti-asthma drugs, refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and ...
Australian Medicines Handbook (AMH) is a peer-reviewed medicines prescribing guide for Australian health professionals. The handbook is available in paper and digital formats and is supplemented by the AMH Aged Care Companion and the AMH Children's Dosing Companion. It is included in the Clinical Information Access Portal.
The APF was originally a pocket-sized booklet first published in 1902, used by physicians as a drugs reference in Australia. In later editions, rather than simply being a listing of pharmaceuticals, medical and clinical information became incorporated within the publication as well, and eventually the title of the APF was extended to the Australian Pharmaceutical Formulary and Handbook.
Download as PDF; Printable version; In other projects ... 1969 and 1970 was a Research Fellow of The Asthma Foundation of New South Wales also ... Handbook of Iodine ...
Later research found that the combination was no more effective for asthma than theophylline alone but produced more side effects. [ 9 ] [ 1 ] [ 12 ] [ 7 ] Combinations of theophylline, ephedrine, and phenobarbital (brand name Tedral among others) have also been widely used to treat asthma.
Clenbuterol is approved for use in some countries as a bronchodilator for asthma. [medical citation needed]Clenbuterol is a β 2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol, but its effects are more potent and longer-lasting as a stimulant and thermogenic drug.
ASCIA was formed in 1991 by the merging of the Australian College of Allergy with the Australasian Society of Immunology Clinical Immunology Group. [ 1 ] ASCIA publishes guidelines and position statements on the management of allergy and other immune diseases, provides online training courses, online educational resources, hosts the ASCIA ...
The medical uses for Cysteinyl-leukotriene type 1 receptor antagonists are for chronic and prophylactic treatment of asthma. [3] [9] [10] Other indications have been approved by the FDA for montelukast and they are used for the prevention of exercise-induced bronchoconstriction (EIB), relief of symptoms of allergic rhinitis (AR) that is for relief of seasonal allergic rhinitis and perennial ...